HIV-1: microRNA interactions
HIV-1:微小RNA相互作用
基本信息
- 批准号:8233429
- 负责人:
- 金额:$ 38.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityApplications GrantsBindingBinding SitesBiological AssayCD4 Positive T LymphocytesCell physiologyCellsCocaineCocaine AbuseComplexDevelopmentDisease ProgressionDrug abuseGene ExpressionGenomeGrantHIV-1HealthHerpesviridaeHumanImmunoprecipitationIndividualInfectionLeadLightMalignant NeoplasmsMessenger RNAMicroRNAsMolecular ProfilingMonoclonal AntibodiesMutatePathogenesisPatientsPatternPharmaceutical PreparationsPlayPolyomavirusPoriferaPositioning AttributeProcessProductionRNARNA InterferenceRNA-Induced Silencing ComplexRecoveryReport (account)ResearchRibonucleosidesSiteSmall Interfering RNAT-LymphocyteTechnologyTestingTranslationsViralVirionVirusVirus DiseasesVirus ReplicationWestern Blottingabstractingcell growth regulationcrosslinkin vivointerestknock-downmRNA Expressionmacrophagenon-drugnovel strategiesparticleprograms
项目摘要
DESCRIPTION (provided by applicant): Abstract MicroRNAs (miRNAs) are a recently discovered class of small, ~22-nt regulatory RNAs that are now known to play key roles in the regulation of cellular differentiation and development. Misregulation of miRNA expression can contribute to disease progression, particularly in the case of cancer, and recent evidence also implicates miRNAs in aspects of viral replication and pathogenesis. Several viruses, including numerous herpesviruses and polyomavirus species, are now known to express a range of virally-encoded miRNAs, and virus infection is also known to perturb cellular miRNA expression in ways that may facilitate virus replication. Although relatively little is know about how HIV-1 interacts with the cellular miRNA machinery, it appears clear that HIV-1 infection can modify the pattern of cellular miRNA expression, and individual cellular miRNAs have been proposed to either facilitate or inhibit HIV-1 replication. It also remains possible that HIV-1 may encode one or more miRNAs, although this has been controversial. In this grant application, we propose to systematically analyze the effect of HIV-1 infection on the pattern of miRNA expression in primary CD4+ T cells and macrophages using microarray and deep sequencing technologies. We will then use cross-linking immunoprecipitation (CLIP) technologies to identify all the RNA induced silencing complex (RISC) binding sites on all the mRNAs expressed in HIV-1-infected cells by using an Argonaute-specific monoclonal antibody to recover cross-linked mRNA:RISC complexes, which we will then analyze by deep sequencing. Cellular or HIV- 1 mRNAs that are targeted by miRNAs expressed in HIV-1-infected cells will then be subjected to mutational analysis, combined with functional assays, to identify mRNA:miRNA interactions that modulate the efficiency of HIV-1 replication. Finally, we will determine whether drug-specifically cocaine-abuse modifies the miRNA expression profile in uninfected and HIV-1-infected CD4+ T cells and macrophages and we will examine whether any drug-induced changes in the miRNA profile can account for the reported enhancement in HIV-1 replication in cells isolated from drug-abusing patients. Together, this analysis will lead to a comprehensive understanding of how HIV-1 infection modifies the miRNA expression profile and will provide a mechanistic understanding of how these changes regulate the efficiency of HIV-1 replication. PUBLIC HEALTH RELEVANCE: Relevance MicroRNAs (miRNAs) are a class of small regulatory RNAs that are thought to regulate a wide range of cellular processes. We will determine how HIV-1 infection changes the pattern of miRNA expression and whether HIV-1 makes its own miRNAs. We will then determine whether these changes enhance viral replication and define the mechanisms underlying this enhancement in both normal and drug-abusing patients. This research has the potential to not only shed new light on HIV-1 pathogenesis but also suggest new approaches to inhibit virus replication.
描述(由申请人提供):摘要微小RNA(miRNAs)是最近发现的一类小的、~22-nt的调节RNA,现在已知其在细胞分化和发育的调节中起关键作用。miRNA表达的失调可能导致疾病进展,特别是在癌症的情况下,最近的证据也表明miRNA与病毒复制和发病机制有关。现在已知几种病毒,包括许多疱疹病毒和多瘤病毒物种,表达一系列病毒编码的miRNA,并且还已知病毒感染以可能促进病毒复制的方式干扰细胞miRNA表达。虽然对HIV-1如何与细胞miRNA机制相互作用知之甚少,但似乎很清楚HIV-1感染可以改变细胞miRNA表达的模式,并且已经提出单个细胞miRNA可以促进或抑制HIV-1复制。HIV-1也可能编码一个或多个miRNA,尽管这一直存在争议。在这项资助申请中,我们建议使用微阵列和深度测序技术系统地分析HIV-1感染对原代CD 4 + T细胞和巨噬细胞中miRNA表达模式的影响。然后,我们将使用交联免疫沉淀(CLIP)技术,通过使用Argonaute特异性单克隆抗体来识别HIV-1感染细胞中表达的所有mRNA上的所有RNA诱导沉默复合物(RISC)结合位点,以恢复交联的mRNA:RISC复合物,然后我们将通过深度测序进行分析。然后将HIV-1感染细胞中表达的miRNA靶向的细胞或HIV- 1 mRNA进行突变分析,结合功能测定,以鉴定调节HIV-1复制效率的mRNA:miRNA相互作用。最后,我们将确定药物特异性可卡因滥用是否会改变未感染和HIV-1感染的CD 4 + T细胞和巨噬细胞中的miRNA表达谱,我们将检查是否有任何药物诱导的miRNA谱变化可以解释从药物滥用患者中分离的细胞中HIV-1复制的增强。总之,这种分析将导致对HIV-1感染如何改变miRNA表达谱的全面理解,并将提供对这些变化如何调节HIV-1复制效率的机制理解。公共卫生相关性:相关性微RNA(miRNA)是一类小的调控RNA,被认为调节广泛的细胞过程。我们将确定HIV-1感染如何改变miRNA表达模式以及HIV-1是否产生自己的miRNA。然后,我们将确定这些变化是否会增强病毒复制,并确定在正常和药物滥用患者中这种增强的机制。这项研究不仅有可能为HIV-1的发病机制提供新的线索,而且还提出了抑制病毒复制的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRYAN R. CULLEN其他文献
BRYAN R. CULLEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRYAN R. CULLEN', 18)}}的其他基金
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
- 批准号:
10158875 - 财政年份:2021
- 资助金额:
$ 38.07万 - 项目类别:
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
- 批准号:
10369728 - 财政年份:2021
- 资助金额:
$ 38.07万 - 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
- 批准号:
10371249 - 财政年份:2018
- 资助金额:
$ 38.07万 - 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
- 批准号:
9894777 - 财政年份:2018
- 资助金额:
$ 38.07万 - 项目类别:
Effect of m6A editing of RNA on influenza A virus replication
RNA m6A 编辑对甲型流感病毒复制的影响
- 批准号:
9296268 - 财政年份:2017
- 资助金额:
$ 38.07万 - 项目类别:
Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases
使用 CRISPR/Cas 核酸内切酶破坏潜伏的 HIV-1 原病毒
- 批准号:
9427958 - 财政年份:2015
- 资助金额:
$ 38.07万 - 项目类别:
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
使用细菌 CRISPR/Cas 核酸内切酶选择性消除体内 HPV 转化细胞
- 批准号:
9136078 - 财政年份:2015
- 资助金额:
$ 38.07万 - 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
- 批准号:
8849841 - 财政年份:2014
- 资助金额:
$ 38.07万 - 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
- 批准号:
8762673 - 财政年份:2014
- 资助金额:
$ 38.07万 - 项目类别:
Role and mechanism of action of gamma herpesvirus microRNAs
γ 疱疹病毒 microRNA 的作用和作用机制
- 批准号:
8293437 - 财政年份:2011
- 资助金额:
$ 38.07万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 38.07万 - 项目类别:
Continuing Grant